Managing the Economic Challenges in the Treatment of Heart Failure

Ileana L Piña1, Nihar R Desai2, Larry A Allen3

  • 1Montefiore Medical Center, Bronx, New York, United States of America.

Insights

The economics of heart failure (HF) impacts all stakeholders. Evolving quality-based payment systems from the Centers for Medicare and Medicaid Services (CMS) challenge healthcare providers, necessitating data for improved care and cost reduction.

Area of Science:

  • Health Economics
  • Cardiology
  • Healthcare Policy

Background:

  • Heart failure (HF) presents significant economic challenges for patients, families, and healthcare systems.
  • The Centers for Medicare and Medicaid Services (CMS) actively targets HF for cost-reduction and quality improvement initiatives.
  • The healthcare payment landscape is shifting from volume-based to quality-based systems, impacting HF care.

Purpose of the Study:

  • To review the implications of CMS payment programs on health systems managing heart failure.
  • To discuss the challenges and opportunities presented by evolving quality assessment and payment models in HF care.

Main Methods:

  • Proceedings from a symposium held at the Heart Failure Society of America conference (September 15, 2018).
  • Review of current CMS payment programs and their effects on healthcare providers treating HF patients.

Main Results:

  • Quality-based payment systems with performance metrics are increasingly replacing traditional fee-for-service models.
  • There is a recognized need for more data to guide decision-making in improving HF care quality and reducing costs.
  • The transition to new payment models presents ongoing challenges for hospitals and HF specialists.

Conclusions:

  • Healthcare systems must adapt to the evolving financial and quality assessment landscape driven by CMS.
  • Further research and data are crucial to effectively navigate the economic complexities of heart failure management.
  • Understanding and responding to CMS initiatives is vital for sustainable and high-quality HF care.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966